1-20 of 42
Peter Liebisch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patterns of Renal Recovery and Toxicity with Novel Agent-Based Induction Triplets in Newly Diagnosed Multiple Myeloma - an Analysis of Two Prospective Studies By the German DSMM Myeloma Study Group

Friederike Bachmann, MD, Swantje Held, Monika Engelhardt, MD, Christian Langer, MD, Denise Wolleschak, Janik Fleissner, Lars-Olof Mügge, MD, Heinz Duerk, MD PhD, Martin Schreder, MD, Kerstin Schaefer-Eckart, MD, Igor-Wolfgang Blau, MD PhD, Martin Gramatzki, MD, Peter Liebisch, MD, Albrecht Reichle, MD, Ivana Metzler, MD, Florian Bassermann, MD PhD, Bernd Metzner, MD PhD, Christoph Röllig, MD MSC, Bernd Hertenstein, Tobias Dechow, Wolfram Jung, MD, Helmut Ostermann, MD, Holger Hebart, Georg Maschmeyer, MD, Hans Jürgen Salwender, MD, Marie von Lilienfeld-Toal, MD, Kai-Uwe Eckardt, MD, Christian Straka, MD PhD, Hermann Einsele, MD, Stefan Knop
Journal: Blood
Blood (2019) 134 (Supplement_1): 1840.
https://doi.org/10.1182/blood-2019-125235
Published: 2019
Journal Articles

Bortezomib Consolidation Following Autologous Transplant Equalizes the Outcome for Older Patients with Less Intensive Pretreatment Compared to Younger Patients with Newly Diagnosed Multiple Myeloma

Christian Straka, MD, Stefan Knop, MD, Martin Vogel, MD PhD, Jurgen Müller, Dipl. Stat., Martin Kropff, MD, Bernd Metzner, MD, Christian Langer, MD, Herbert Sayer, MD, Wolfram Jung, MD, Heinz Dürk, MD PhD, Hans-Juergen Salwender, MD, Hannes Wandt, MD, PhD, Florian Bassermann, MD, Martin Gramatzki, MD, Wolf Rösler, MD, Hans-Heinrich Wolf, MD, Wolfram Brugger, MD PhD, Monika Engelhardt, MD, Thomas Fischer, MD, Peter Liebisch, MD, Hermann Einsele, MD
Journal: Blood
Blood (2016) 128 (22): 516.
https://doi.org/10.1182/blood.V128.22.516.516
Published: 2016
Journal Articles

Autologous Followed By Allogeneic Versus Tandem-Autologous Stem Cell Transplant in Newly Diagnosed FISH-del13q Myeloma

Stefan Knop, MD, Peter Liebisch, MD, Holger Hebart, MD, Ernst Holler, MD, Monika Engelhardt, MD, Bernd Metzner, MD, Dietrich Peest, MD, Walter Aulitzky, MD, Donald W. Bunjes, MD, Christian Straka, MD, Thomas Fischer, MD, Hannes Wandt, MD, Orhan Sezer, MD, Markus Hentrich, MD, Helmut Ostermann, MD, Christian Peschel, MD, Georg Hess, MD, Bernd Hertenstein, MD, Mathias Freund, MD, Martin H Kropff, MD, Hans-Heinrich Wolf, MD, Wolfram E Jung, MD, Norbert Frickhofen, MD, Ralf C. Bargou, Georg Maschmeyer, MD, Else Heidemann, MD, Christian Langer, MD, Lothar Kanz, MD, Christoph Meisner, PhD, Hermann Einsele, MD
Journal: Blood
Blood (2014) 124 (21): 43.
https://doi.org/10.1182/blood.V124.21.43.43
Published: 2014
Journal Articles

Survival Analysis in Patients with Multiple Myeloma after Allogeneic Hematopoietic Stem Cell Transplantation, a Single Center Study (1994-2013)

Susanne Hofmann, MD, Lisa Müller, Stephanie Harsdorf, MD, Christian Langer, MD, Peter Liebisch, MD, Jochen Greiner, MD, Hartmut Döhner, MD, Donald Bunjes, MD
Journal: Blood
Blood (2014) 124 (21): 1233.
https://doi.org/10.1182/blood.V124.21.1233.1233
Published: 2014
Journal Articles

Outcome and Prognostic Factors of 17p Deleted Multiple Myeloma Patients

Miriam Kull, MD, Veronica Teleanu, MD, Daniela Hayde, Katrin Wildbihler, Stephanie Harsdorf, MD, Donald Bunjes, MD, Peter Liebisch, MD, Christian Langer, MD
Journal: Blood
Blood (2014) 124 (21): 3994.
https://doi.org/10.1182/blood.V124.21.3994.3994
Published: 2014
Journal Articles

Expression of Cereblon ( CRBN ) Is Associated with Disease Stage, Genetic Subgroups and Specific Micro-RNAs in Multiple Myeloma

Florian Kuchenbauer, MD, PhD, Johannes Bloehdorn, MD, Miriam Kull, MD, Peter Liebisch, MD, Veronica Teleanu, MD, Britta Kopp, Stefan Knop, Christian Straka, Hermann Einsele, Hartmut Döhner, MD, Christian Langer
Journal: Blood
Blood (2012) 120 (21): 1820.
https://doi.org/10.1182/blood.V120.21.1820.1820
Published: 2012
Journal Articles

IDH1 and IDH2 mutations are Not Frequent In Multiple Myeloma

Christian Langer, MD, Mariam Ibañez, Peter Liebisch, MD, Thorsten Zenz, MD, Stefan Knop, MD, Hermann Einsele, MD, Peter Paschka, MD, Hartmut Doehner, MD, Konstanze Doehner, MD
Journal: Blood
Blood (2010) 116 (21): 4992.
https://doi.org/10.1182/blood.V116.21.4992.4992
Published: 2010
Journal Articles

Prognostic Impact of Chromosomal Abnormalities In Elderly Patients with Multiple Myeloma Treated with High-Dose Melphalan (MEL140) and Autologous Stem Cell Transplantation

Peter Liebisch, Christian Straka, Hermann Einsele, MD, Axel Hinke, Andreas Sandermann, Hartmut Dohner, MD, Christian Langer, MD
Journal: Blood
Blood (2010) 116 (21): 1914.
https://doi.org/10.1182/blood.V116.21.1914.1914
Published: 2010
Journal Articles

OPTIMUM Dose of Thalidomide for Relapsed Multiple Myeloma.

Martin Kropff, Honorata Giongco Baylon, MD, Jens Hillengass, MD, Tadeusz Robak, Roman Hajek, MD, Peter Liebisch, MD, Stefan Goranov, MD, Cyrille Hulin, Joan Blade, Tomaso Caravita, Herve Avet-Loiseau, MD, PhD, Thomas M. Moehler, Claire Pattou, Lela Lucy, Elisabeth Kueenburg, Axel Glasmacher, MD, Robert Zerbib, Thierry Facon
Journal: Blood
Blood (2009) 114 (22): 959.
https://doi.org/10.1182/blood.V114.22.959.959
Published: 2009
Journal Articles

Allogeneic Stem Cell Transplant Versus Tandem High-Dose Melphalan for Front-Line Treatment of Deletion 13q14 Myeloma – An Interim Analysis of the German DSMM V Trial.

Stefan Knop, MD, Peter Liebisch, MD, Holger Hebart, Ernst Holler, PhD, Monika Engelhardt, Ralf C Bargou, MD, Bernd Metzner, Dietrich Peest, Walter E. Aulitzky, MD, Hannes Wandt, MD, Orhan Sezer, MD, PhD, Markus Hentrich, Helmut Ostermann, Christian Peschel, MD, Georg Hess, Bernd Hertenstein, Mathias Freund, MD, Martin H Kropff, Hans-Heinrich Wolf, Wolfram Jung, Norbert Frickhofen, MD, Georg Maschmeyer, Hans-Guenther Mergenthaler, Else Heidemann, Nicolaus Kröger, MD, Christian Straka, Corinna Engel, Lothar Kanz, Christoph Meisner, Hermann Einsele, MD
Journal: Blood
Blood (2009) 114 (22): 51.
https://doi.org/10.1182/blood.V114.22.51.51
Published: 2009
Journal Articles

Velcade, Intravenous Cyclophosphamide and Dexamethasone (VCD) Induction for Previously Untreated Multiple Myeloma (German DSMM XIa Trial).

Hermann Einsele, Peter Liebisch, Christian Langer, Martin Kropff, Hannes Wandt, Wolfram Jung, Nikolaus Kröger, Monika Engelhardt, Helmut Ostermann, Lars-Olof Mügge, Hans-Heinrich Wolf, Christina Hart, Bernd Metzner, Martin Kaufmann, Martin Gramatzki, Bernd Hertenstein, Thomas Fischer, Katja Weisel, Gottfried Dölken, Wolfram Brugger, Hella Gollasch, Georg Maschmeyer, Michael Pfreundschuh, Norbert Schmitz, Orhan Sezer, Else Heidemann, Elke Jäger, Christoph Kahl, Alexander Kiani, Tobias Dechow, Wolf Rösler, Jan Philipp Simon, Heinz Dürk, Karl Heinz Pflüger, Martin Bentz, Georg Hess, Hans-Guenther Mergenthaler, Christian Straka, Dirk Hempel, Hans-Jürgen Salwender, Günter Fingerle-Rowson, Stefan Knop
Journal: Blood
Blood (2009) 114 (22): 131.
https://doi.org/10.1182/blood.V114.22.131.131
Published: 2009
Journal Articles

Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom)

Clinical Trials & Observations
Stefan Knop, Christian Gerecke, Peter Liebisch, Max S. Topp, Uwe Platzbecker, Orhan Sezer, Christina Vollmuth, Karina Falk, Axel Glasmacher, Uwe Maeder, Hermann Einsele, Ralf C. Bargou
Journal: Blood
Blood (2009) 113 (18): 4137–4143.
https://doi.org/10.1182/blood-2008-10-184135
Published: 2009
Journal Articles

Incorporation of the Bone Marker Carboxy-Terminal Telopeptide of Type-1 Collagen (ICTP) into a Combined ISS-ICTP Score Improves the Prognostic Significance of the ISS in Newly Diagnosed Symptomatic Multiple Myeloma and Identifies a Very Low Risk Group Which Has No Benefit from High-Dose Therapy

Christian Jakob, MD, Peter Liebisch, MD, Ulrike Heider, MD, Martin Kaiser, MD, Jan Sterz, MD, Jessica Rademacher, MD, Claudia Fleissner, MD, Christian Müller, MD, Orhan Sezer, MD
Journal: Blood
Blood (2008) 112 (11): 2721.
https://doi.org/10.1182/blood.V112.11.2721.2721
Published: 2008
Journal Articles

Bortezomib, Intravenous Cyclophosphamide and Dexamethasone (VelCD) for Previously Untreated Multiple Myeloma: An Interim Analysis of the German DSMM XIa Trial

Stefan Knop, MD, Peter Liebisch, MD, Hannes Wandt, MD, Martin Kropff, MD, Volker Kunzmann, MD, Katja Weisel, MD, Daniel Franke, MD, Monika Engelhardt, MD, Lorenz H. Truemper, MD, PhD, Nikolaus Kroeger, MD, Burkhard Hennemann, MD, Michael Pfreundschuh, MD, PhD, Martin Gramatzki, MD, Bernd Metzner, MD, Christian Peschel, MD, Herbert G. Sayer, MD, PhD, Orhan Sezer, MD, Heinz A Duerk, MD, Bernd Hertenstein, MD, Hans-Guenther Mergenthaler, MD, Hella Gollasch, MD, Hans-Heinrich Wolf, MD, Georgia Schilling, MD, Claas Frohn, MD, Hermann Einsele, MD
Journal: Blood
Blood (2008) 112 (11): 2776.
https://doi.org/10.1182/blood.V112.11.2776.2776
Published: 2008
Journal Articles

Lenalidomide, Adriamycin and Dexamethason (RAD) in Relapsed and Refractory Multiple Myeloma: Final Results from a Phase I/II Trial of “Deutsche Studiengruppe Multiples Myelom”

Christian Gerecke, Stefan Knop, Max S. Topp, Peter Liebisch, Christina Vollmuth, Uwe Platzbecker, Uwe Mäder, Hermann Einsele, Ralf C. Bargou
Journal: Blood
Blood (2008) 112 (11): 2782.
https://doi.org/10.1182/blood.V112.11.2782.2782
Published: 2008
Journal Articles

Association of Elevated Circulating Proteasome Levels at Diagnosis with Poor Outcome in Multiple Myeloma

Peter Liebisch, MD, Stephan Sixt, MD, Hagen S Bachmann, MD, Ulrich H Frey, MD, Juergen Peters, MD, Hartmut Doehner, MD, PhD, Ulrich Duehrsen, MD, Holger Nückel, MD
Journal: Blood
Blood (2008) 112 (11): 5140.
https://doi.org/10.1182/blood.V112.11.5140.5140
Published: 2008
Journal Articles

Detection of Renal Impairment (RI) as One Specific Comorbidity Factor in Multiple Myeloma (MM) Patients: Multi-Center Study in 198 Consecutive Patients

Martina Kleber, Gabriele Ihorst, Barbara Deschler, Christian Jakob, MD, Peter Liebisch, Bernd Koch, Orhan Sezer, Monika Engelhardt
Journal: Blood
Blood (2008) 112 (11): 2372.
https://doi.org/10.1182/blood.V112.11.2372.2372
Published: 2008
Journal Articles

A Functional Promoter Polymorphism (−8C>G) of the Proteasome Subunit α6 Gene Is Associated with Multiple Myeloma and Poor Outcome Independent of Circulating Proteasome Serum Levels.

Hagen S Bachmann, MD, Juergen Novotny, MD, Stephan Sixt, MD, Peter Liebisch, MD, Ulrich Frey, MD, Juergen Peters, MD, Ulrich Duehrsen, MD, Winfried Siffert, MD, Holger Nückel, MD
Journal: Blood
Blood (2008) 112 (11): 1668.
https://doi.org/10.1182/blood.V112.11.1668.1668
Published: 2008
Journal Articles

RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses

Michael Schmitt, Anita Schmitt, Markus T. Rojewski, Jinfei Chen, Krzysztof Giannopoulos, Fei Fei, Yingzhe Yu, Marlies Götz, Marta Heyduk, Gerd Ritter, Daniel E. Speiser, Sacha Gnjatic, Philippe Guillaume, Mark Ringhoffer, Richard F. Schlenk, Peter Liebisch, Donald Bunjes, Hiroshi Shiku, Hartmut Dohner, Jochen Greiner
Journal: Blood
Blood (2008) 111 (3): 1357–1365.
https://doi.org/10.1182/blood-2007-07-099366
Published: 2008
Journal Articles

A Multi-Center Analysis of Renal Impairment as a Potential Prognostic Factor: Analysis in Multiple Myeloma Patients Treated with Standard or High-Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation.

Martina Kleber, MD, Gabriele Ihorst, PhD, Christian Jakob, MD, Peter Liebisch, MD, Bernd Koch, PhD, Monika Engelhardt, MD
Journal: Blood
Blood (2007) 110 (11): 4830.
https://doi.org/10.1182/blood.V110.11.4830.4830
Published: 2007